Table 2.
Test at diagnosis of BP | |
---|---|
Physical examination | In particular spleen and liver size [cm below the costal margin], extramedullary manifestation of disease |
Complete Blood Count |
Full white blood cell (WBC) count Hemoglobin (Hb) and platelet count, neutrophils, lymphocytes, monocytes, Basophils %, Eosinophils %, Blasts %, Sum of Blasts % + Promyelocytes % |
Bone Marrow |
Morphology Blast % and Promyelocytes % Cytogenetics (for Ph-positive and/or additional chromosomal aberrations) with a minimum of 15 metaphases analyzed Fluorescent-in-situ-hybridization (FISH) if marrow cytogenetics fails Trephine biopsy (assessment of focal “nests of blasts” and fibrosis |
Flow cytometry and/or cytochemistry | Definition of phenotype by expression of cell-surface and cytoplasmic markers (myeloid vs. lymphoid) |
Molecular genetics |
BCR::ABL1 fusion transcript (e13a2, e14a2, e1a2 or any rare type) BCR::ABL1 transcript level quantitative analysis (on the IS scale) Tyrosine kinase domain mutation analysis NGS myeloid or lymphoid panel |
Cerebrospinal Fluid |
Cytology Intrathecal injection for CNS prophylaxis (for details see text) |
Human leukocyte antigen (HLA)-typing | Donor search for allogeneic stem cell transplantation |